Fortitude Family Office »

Amneal Pharmaceuticals shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.0k 966 8.32
2024-06-30 $6.1k 966 6.35
2024-03-31 $5.9k 966 6.06
2023-12-31 $5.9k 966 6.07

More positions owned by Fortitude Family Office

Apple Stock (AAPL)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Ishares Core S&p 500 Etf Etf (IVV)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Vanguard Mid-cap Etf Etf (VO)
Ishares Tips Bond Etf Etf (TIP)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Ishares Core S&p Small Cap Etf Etf (IJR)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Avantis International Small Cap Value Etf Etf (AVDV)
Ishares Msci Emerging Markets Ex China Etf Etf (EMXC)
Jpmorgan Ultra-short Income Etf Etf (JPST)
Kkr & Co Stock (KKR)

View all positions for Fortitude Family Office

Top funds holding Amneal Pharmaceuticals

Vanguard Group
BlackRock
Tpg Gp A
BlackRock
Rubric Capital Management
Citadel Advisors
Dimensional Fund Advisors
Fosun International
Geode Capital Management
Neuberger Berman Group
State Street Corporation
Nantahala Capital Management
Nuveen Asset Management
Invesco
Arrowstreet Capital, Limited Partnership

View all funds holding Amneal Pharmaceuticals